Search

everythinglearnresearchcommunity

for

Search:↓

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The treatment was not recommended due to limited effectiveness and significant side effects.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Several doctors received research grants, new workshops and conferences were announced, and new officers were elected.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Alopecia is common in severe cases of autosomal recessive congenital ichthyosis.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Skin reactions to antidepressants are common but usually not serious and can be treated.

New medications could improve treatment for severe alopecia areata in Australia.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

Zinc supplements effectively treat inherited zinc deficiency in infants.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Adiantum capillus extract reduces pain and swelling in animals.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

AMT® is effective and safe for early-stage knee osteoarthritis.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.